According to research presented today at ESC Congress 2024, patients with stable coronary artery disease who quit smoking at any timepoint after their diagnosis reduced their risk of a major event by almost 50%.
Psyence Group Corporate Update | Psychedelic Invest
Psyence Group Inc. (CSE: PSYG / OTCQB: PSYGF) is pleased to provide the following corporate update on its strategic focus areas namely: Psyence Therapeutics and Psyence Production. The